Michael Arzt, MD, investigated the use of ASV therapy in patients with TE-CSA and cardiovascular disease, finding it effective in reducing sleepiness and improving quality of life. It may be more ...
Medical device company ResMed Inc. RMD recently sponsored a study which shows potential treatment of obstructive sleep apnea (OSA) in patients with untreated central sleep apnea (CSA). According to ...
- Largest-ever analysis of patients with treatment-emergent central sleep apnea shows switching from CPAP to ASV significantly improves compliance - Study highlights the need to consider therapeutic ...
On May 15, 2015, Respironics, Inc., a Philips business, provided the following response to ResMed's Update on Phase IV SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy in Central Sleep Apnea ...
Overview Effect of Narcotics on Respiratory Physiology Treatment of Opioid-Induced Sleep-Disordered Breathing References Treatment of Opioid-Induced Sleep-Disordered Breathing The treatment of ...
March 7 (Reuters) - Respironics Inc. said U.S. regulators granted approval to market its ventilatory support device, BiPAP autoSV, for sleep-disordered breathing patients. The company said the device ...
Royal Philips ($PHG) said it is working with ResMed ($RMD) to analyze study data from mid-May showing that the latter company's Adaptive Servo-Ventilation (ASV ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results